Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission

Journal of Infectious Diseases

Volumn 183, Issue 4, 2001, Pages 653-656

  Pillay, Kubendran ^a   Coutsoudis, Anna ^a   Agadzi Naqvi, Anthony K ^b   Kuhn, Louise ^c   Coovadia, Hoosen M ^a   Janoff, Edward N ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RETINOL; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERINATAL PERIOD; PRIORITY JOURNAL; VAGINA; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION;

CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RNA, VIRAL; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; VAGINAL DISCHARGE; VITAMIN A;

EID: 0035865916     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/318535     Document Type: Article

References (15)

1. Mechanisms and timing of mother-to-child transmission of HIV-1
2. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission
3. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
4. Tissue distribution of antileukoprotease and lysozyme in humans
5. Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro
6. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to reverse transcription
7. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro
8. Lysozyme and RNases as anti-HIV components in b-core preparations of human chorionic gonadotropin
9. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa
10. Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity
11. Effects of vitamin A supplementation on viral load in HIV-1-infected pregnant women
12. Human immunodeficiency virus type 1 and mucosal humoral defense
13. Human neutralising monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
14. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralising antibodies
15. HIV-1 detection in cervico-vaginal secretion during pregnancy